Pharmacytimes: Condition Center: Heart Failure Heart Failure en-us Wed, 29 Mar 2017 10:54:13 UTC Wed, 29 Mar 2017 10:54:13 UTC Pharmacists and Heart Failure: Room for Intervention in Every Practice Setting Heat failure (HF) caused 1 in 9 deaths in the United States in 2009.&nbsp; 1:26 PM, Tue March 28, 2017 FDA Accepts NDA for Investigational Hypertension Drug The FDA has accepted&nbsp;the new drug application (NDA) for EZR-201, an investigational product from Ezra Innovations for the treatment of hypertension and heart failure.&nbsp; 10:23 AM, Fri January 20, 2017 Heart Failure Risk Reduction Strategies and Transition of Care In this clip, Dr. Peter Salgo,<strong> </strong>a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital discusses heart failure.&nbsp; 4:17 PM, Thu December 29, 2016 Flashcards and QR Codes Improve Medication Adherence in Patients with Diabetes, Hypertension, and Heart Failure Poor medication adherence contributes to 125,000 deaths annually, causes up to half of all treatment failures, and costs the US healthcare system $100 billion each year. 9:00 AM, Tue November 15, 2016 Heart Failure Treatment Strategies for Patients with Diabetes The incidence of heart failure is increasing as the world’s population ages and the rates of other, often comorbid, diseases (eg, diabetes, heart disease, obesity) increase. 8:00 AM, Tue October 25, 2016 Is It Time to Move On From Tolvaptan for Acute Heart Failure? This article summarizes recent literature surrounding the use of tolvaptan for acute heart failure. 4:30 AM, Wed September 28, 2016 Are ACE Inhibitors Interchangeable? That is, are they all equally effective? 10:04 PM, Mon September 19, 2016 Could CoQ10 Benefit Heart Failure Patients? Supplemental coenzyme Q10 may be a management option for patients with heart failure. 8:57 AM, Tue August 9, 2016 FDA Approves First Lisinopril Oral Solution The FDA has approved Silvergate Pharmaceuticals’ Qbrelis, the first lisinopril oral solution. 8:00 AM, Fri August 5, 2016 Heart Failure Therapy: The Good, the Bad, and the Ugly This article highlights the latest literature surrounding both new and old heart failure therapies. 9:52 PM, Tue August 2, 2016 Common Medications Can Trigger Heart Failure The American Heart Association has released a scientific statement cautioning against the use of some common drugs and supplements in patients with heart failure. 10:04 PM, Sun July 17, 2016 Should SSRIs Be Prescribed for Depression in Heart Failure Patients? Depression affects 10% to 40% of patients with heart failure, depending on disease severity. 8:38 AM, Fri July 8, 2016 Why Entresto Is a Winner for Heart Failure Two new analyses have further cemented Entresto’s place in heart failure therapy. 10:24 PM, Mon July 4, 2016 Can Vitamin D Supplementation Benefit Heart Failure Patients? This article explores recent evidence describing the potential benefits of vitamin D supplementation in patients with heart failure and reduced ejection fraction. 11:44 PM, Sun June 5, 2016 Heart Failure Guideline Update Puts Trust in Entresto The American College of Cardiology, American Heart Association, and Heart Failure Society of America recently updated guidelines for pharmacological heart failure treatment, focusing specifically on 2 new agents. 9:44 PM, Wed June 1, 2016 Updated Heart Failure Guidelines Highlight Role of Entresto, Corlanor The American College of Cardiology, the American Heart Association, and the Heart Failure Society of America have updated heart failure guidelines to recommend the use of 2 medications: sacubitril/valsartan (Entresto) and ivabradine (Corlanor). 1:00 AM, Tue May 24, 2016 New Heart Failure Guidelines: What Pharmacists Need to Know This article highlights the latest evidence from both the AHA/ACC and ESC guidelines, which were both published this past weekend. 9:10 PM, Sun May 22, 2016 Entresto Shows Benefit Even in Clinically Stable Heart Failure Patients Novartis’ sacubitril/valsartan (Entresto) is showing promise for heart failure patients with reduced ejection fraction, regardless of background therapy or clinical stability. 7:00 AM, Thu April 14, 2016 4 Heart Failure Management Tips for Community Pharmacists the community pharmacist is in a unique position to provide another level of education to heart failure patients. 10:17 PM, Wed February 10, 2016 5 Things Pharmacists Should Know About Patients with Left Ventricular Assist Devices Left ventricular assist devices have emerged as a lifesaving treatment option for those with advanced heart failure. 10:08 PM, Tue February 9, 2016